Outcome of patients after ACT
| . | Outcome of patients/patients evaluable until 6 mo after ACT* . | Days after ACT . | Outcome of patients/patients evaluable until last observation after ACT† . | Days after ACT . | ||
|---|---|---|---|---|---|---|
| Mean . | Range . | Mean . | Range . | |||
| Survivors after ACTठ| 15/30 | 7/30 | ||||
| Responders | 15/21 | 7/21 | ||||
| Nonresponders | 0/8 | 0/8 | ||||
| Death after ACT§ | 15 | 61 | 2-184 | 23 | 137 | 2-428 |
| Responders|| | 6 | 122 | 33-184 | 14 | 211 | 33-428 |
| With final clearance of viremia | 4 | 151 | 134-184 | 9 | 209 | 134-391 |
| Without final clearance of viremia | 2 | 62 | 33-91 | 62 | 33-91 | |
| Nonresponders | 8 | 24 | 9-56 | 24 | 9-56 | |
| Cause of death | ||||||
| AdV-associatedठ| 11/15 | 11/22 | ||||
| Nonresponders | 8/8 | 8/8 | ||||
| Responders with final clearance of viremia | 0/4 | 0/11 | ||||
| Responders without final clearance of viremia | 2/2 | 2/2 | ||||
| Other cause | 4/15 | 11/22 | ||||
| Nonresponders | 0/8 | 0/8 | ||||
| Responders | 4/6 | 11/13 | ||||
| . | Outcome of patients/patients evaluable until 6 mo after ACT* . | Days after ACT . | Outcome of patients/patients evaluable until last observation after ACT† . | Days after ACT . | ||
|---|---|---|---|---|---|---|
| Mean . | Range . | Mean . | Range . | |||
| Survivors after ACTठ| 15/30 | 7/30 | ||||
| Responders | 15/21 | 7/21 | ||||
| Nonresponders | 0/8 | 0/8 | ||||
| Death after ACT§ | 15 | 61 | 2-184 | 23 | 137 | 2-428 |
| Responders|| | 6 | 122 | 33-184 | 14 | 211 | 33-428 |
| With final clearance of viremia | 4 | 151 | 134-184 | 9 | 209 | 134-391 |
| Without final clearance of viremia | 2 | 62 | 33-91 | 62 | 33-91 | |
| Nonresponders | 8 | 24 | 9-56 | 24 | 9-56 | |
| Cause of death | ||||||
| AdV-associatedठ| 11/15 | 11/22 | ||||
| Nonresponders | 8/8 | 8/8 | ||||
| Responders with final clearance of viremia | 0/4 | 0/11 | ||||
| Responders without final clearance of viremia | 2/2 | 2/2 | ||||
| Other cause | 4/15 | 11/22 | ||||
| Nonresponders | 0/8 | 0/8 | ||||
| Responders | 4/6 | 11/13 | ||||
End point of the study.
Data are presented as number of patients. “Days after ACT” represents days to last observation >6 mo after ACT: P2/2689; P3/1805; P7/292; P8/231; P9/391; P11/277; P12/204; P13/1771; P14/1840; P15/218; P19/187; P30/242; P31/2764; P32/428; P35/189.
AdV association with death is unclear for patient 15 (death on day 218 after ACT).
Patient 1 is not classified as a responder or nonresponder because of death 2 days after ACT, but death was AdV-associated.
Patients with negative viremia in blood at ACT who showed clearance of AdV at other sites of infection are included.